Psychedelics are reshaping mental health treatment, showing remarkable potential in alleviating conditions like depression and anxiety, and even enhancing palliative care. While recent studies highlight their effectiveness, challenges remain in standardizing and integrating these therapies into mainstream medicine. This article explores the evolving role of psychedelics and their potential to redefine approaches within the pharmaceutical industry.
